Controlled Release of IgG by Novel UV Induced Polysaccharide/Poly(amino acid) Hydrogels

被引:29
作者
Tripodo, Giuseppe [1 ]
Pitarresi, Giovanna [1 ]
Cavallaro, Gennara [1 ]
Palumbo, Fabio Salvatore [1 ]
Giammona, Gaetano [1 ]
机构
[1] Univ Palermo, Dipartimento Chim & Tecnol Farmaceut, I-90123 Palermo, Italy
关键词
crohn's disease; drug delivery systems; hydrogels; IgG; inulin; polyaspartamide; PHOTO-CROSS-LINKING; ULCERATIVE-COLITIS; INULIN; DRUG; OLIGOFRUCTOSE; INFLIXIMAB; STABILITY; PHARMACOKINETICS; TEMPERATURE; DERIVATIVES;
D O I
10.1002/mabi.200800181
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of new protein and peptide drugs needs new delivery systems able to entrap such drugs in. safe conditions without affecting their structure and biological activity. In this context, the present work reports a new approach to load IgG, used as a model of therapeutic proteins such as anti-TNF-alpha monoclonal antibodies, into a polymeric system able to release the entrapped IgG in a controlled manner. In particular, new polysaccharide/poly(amino acid) UV induced hydrogels are proposed as colon delivery systems for human IgG. The poly(amino acid), alpha,beta-poly[N-(2-hydroxyethyl)-D,L-aspartamide], has been functionalized with methacrylic anhydride, while the polysaccharide, inulin, has been functionalized with methacrylic anhydride and succinic anhydride. The hydrogels were obtained by a short-time UV irradiation, in physiological-like conditions, without the use of radical initiators, at low temperature and in the presence or in the absence of PEGDM(550) used as a co-crosslinker in order to evaluate potential differences in terms of physicochemical properties and release profile. The obtained hydrogels were degradable by inulinase, showed a high cell compatibility and the released antibodies, analyzed by SEC and ELISA, retained their biological activity.
引用
收藏
页码:393 / 401
页数:9
相关论文
共 38 条
[1]   Novel strategies to attenuate immune activation in Crohn's disease [J].
Bamias, Giorgos ;
Cominelli, Fabio .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (04) :401-407
[2]   Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2007, 369 (9573) :1641-1657
[3]   Local injection of infliximab in the postoperative recurrence of Crohn's disease [J].
Biancone, L ;
Cretella, M ;
Tosti, C ;
Palmieri, G ;
Petruzziello, C ;
Geremia, A ;
Calabrese, E ;
Pallone, F .
GASTROINTESTINAL ENDOSCOPY, 2006, 63 (03) :486-492
[4]   Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin [J].
Casellas, F. ;
Borruel, N. ;
Torrejon, A. ;
Varela, E. ;
Antolin, M. ;
Guarner, F. ;
Malagelada, J. -R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (09) :1061-1067
[5]   High concentration formulation feasibility of human immunoglubulin G for subcutaneous administration [J].
Dani, Bhas ;
Platz, Robert ;
Tzannis, Stelios T. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (06) :1504-1517
[6]   Macroporous poly (N-isopropylacrylamide) hydrogels with adjustable size "cut-off" for the efficient and reversible immobilization of biomacromolecules [J].
Faenger, Christian ;
Wack, Holger ;
Ulbricht, Mathias .
MACROMOLECULAR BIOSCIENCE, 2006, 6 (06) :393-402
[7]   Effects of dietary fiber on inflammatory bowel disease [J].
Galvez, J ;
Rodríguez-Cabezas, ME ;
Zarzuelo, A .
MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (06) :601-608
[8]   Inulin and oligofructose: impact on intestinal diseases and disorders [J].
Guarner, F .
BRITISH JOURNAL OF NUTRITION, 2005, 93 :S61-S65
[9]   Directed evolution for drug and nucleic acid delivery [J].
Hida, Kaoru ;
Hanes, Justin ;
Ostermeier, Marc .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (15) :1562-1578
[10]   Controlled trial of oligofructose in the management of irritable bowel syndrome [J].
Hunter, JO ;
Tuffnell, Q ;
Lee, AJ .
JOURNAL OF NUTRITION, 1999, 129 (07) :1451S-1453S